+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prescribing habits in primary biliary cirrhosis: a national survey



Prescribing habits in primary biliary cirrhosis: a national survey



European Journal of Gastroenterology and Hepatology 11(8): 817-820



Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease of unknown aetiology. A number of drugs have been used in its treatment, but only ursodeoxycholic acid (UDCA) has been shown to improve survival. Our aims were to determine the current prescribing habits in PBC of all practising gastroenterologists in the UK. A postal questionnaire was sent to 454 gastroenterologists in 1996, followed by a second questionnaire a month later to the non-responders. Of 454 doctors sent questionnaires, 379 (83%) replied. Of these, 58 were excluded from further analysis as they were not practising gastroenterologists. There are an estimated 4337 patients with PBC being seen by gastroenterologists in hospitals. Of these, only 1376 (32%) are being seen in liver units. Ninety-one per cent of gastroenterologists look after patients with PBC (median 10 patients, range 1-500). Ninety-five per cent of gastroenterologists prescribe UDCA but there is a large dose range (median 11.5 mg/kg/day, range 1.5-23.1). Of these, 93% also prescribe cholestyramine. Only 45 (14%) gastroenterologists prescribed other treatments for PBC (13 colchicine, 24 steroids, nine penicillamine, 13 immunosuppressants). Only 53 (17%) treat the symptoms/complications of PBC (37 fat-soluble vitamins, 15 calcium, six bisphosphonates, one hormone replacement therapy, 10 antihistamines, 10 rifampicin). UDCA is being prescribed for PBC by the majority of practising gastroenterologists but over a wide dose range. Very few gastroenterologists are using preventive treatment for osteoporosis in this high-risk group. Other treatments, as yet unproven in trials, are being prescribed by a minority of gastroenterologists.

(PDF emailed within 1 workday: $29.90)

Accession: 047053921

Download citation: RISBibTeXText

PMID: 10514110


Related references

Primary biliary cirrhosis in Japan: national survey by the Subcommittee on Autoimmune hepatitis. Gastroenterologia Japonica 20(5): 476-485, 1985

Clinical course and prognosis of primary biliary cirrhosis--multivariant analysis on cases of national survey. Nihon Shokakibyo Gakkai Zasshi 86(4): 889-896, 1989

Biochemical, histological parameters and response to UDCA treatment in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Journal of Hepatology 34(Supplement 1): 216, April, 2001

Elevated level of serum Mn-superoxide dismutase in patients with primary biliary cirrhosis: possible involvement of free radicals in the pathogenesis in primary biliary cirrhosis. Journal of Laboratory and Clinical Medicine 118(5): 476-483, 1991

Elevated level of serum manganese superoxide dismutase in patients with primary biliary cirrhosis possible involvement of free radicals in the pathogenesis in primary biliary cirrhosis. Journal of Laboratory & Clinical Medicine 118(5): 476-483, 1991

Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis. Gastroenterology 99(1): 181-186, 1990

Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Hepato-Gastroenterology 49(47): 1195-1200, 2002

Intrahepatic Th1- and Th2-related chemokine receptor mRNA levels in primary biliary cirrhosis and chronic hepatitis C An imbalance between Th1 and Th2 in primary biliary cirrhosis. Hepatology 32(4 Pt 2): 168A, October, 2000

Clinical profile of primary biliary cirrhosis that was diagnosed as symptomatic primary biliary cirrhosis according to the revised diagnostic criteria in Japan. Internal Medicine 49(12): 1073-1078, 2011

Aminoterminal propeptide of type III procollagen and hyaluronan in patients with primary biliary cirrhosis: Markers of fibrosis in primary biliary cirrhosis. Journal of Gastroenterology and Hepatology 11(11): 1016-1020, 1996

Incipient primary biliary cirrhosis/autoimmune hepatitis overlap or hepatitic form of primary biliary cirrhosis: a case report. Cases Journal 2: 7491, 2009

Bronchiolitis obliterans organising pneumonia and primary biliary cirrhosis-like lung involvement in a patient with primary biliary cirrhosis. Clinical Rheumatology 17(3): 246-249, 1998

Liver transplantation for isolated primary biliary cirrhosis and primary biliary cirrhosis with associated autoimmune disease Is there a difference in prognosis?. Gastroenterology 108(4 SUPPL ): A1192, 1995